# Alembic Pharmaceuticals Limited (Units I and II) – FDA Inspection, Oct 8, 2024

Source: https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited-units-i-and-ii/56945324-5d2c-4de3-b337-fddb20579310
Source feed: FDA_Inspections

> FDA inspection 1249881 of Alembic Pharmaceuticals Limited (Units I and II), October 08, 2024. Classification: No Action Indicated (NAI). 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1249881
- Company Name: Alembic Pharmaceuticals Limited (Units I and II)
- Inspection Date: 2024-10-08
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1270216 - 2025-05-31](https://www.keypedia.com/records/fda_inspections/alembic-pharmaceuticals-limited-units-i-and-ii/ba9076d1-2082-46d5-bc86-a9f09fe8f8d6)
- FDA Inspection 1076862 - 2018-12-19
- FDA Inspection 1055013 - 2018-04-23
- FDA Inspection 982077 - 2016-06-29
- FDA Inspection 831397 - 2013-04-18

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kara-a-scheibner/63643a3f-4a8e-4dcc-8f1a-6fcf98519aad)
- [Issuing Officer](https://www.keypedia.com/people/sylvestre-k-dossou/962f9277-7643-4f66-add9-1c3553fa1c14)

Company: https://www.keypedia.com/companies/alembic-pharmaceuticals-limited-units-i-and-ii/68fd4724-f974-4ddc-8882-a5d28dc90916

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
